Skip to content
MARKETS / BALCAO / MWAI
BALCAO · FINANCE SERVICES · SMALL CAP

MedWellAI, Inc. MWAI

14 fiscal years on record · USD · FY2024 reported · SEC filings only
$594,768
$-3.6M
$-850,773
In brief

What this company does

We are a diversified holdings company that develops, acquires, operates, and invests in unique and profitable businesses. Our business focus is on AI-driven healthcare and wellness solutions. Currently, the company operates through their subsidiary MedWell USA, a B2B e-commerce platform for distributing pharmaceutical products, particularly GLP medications for weight loss and diabetes management. It features an AI-powered ordering system with real-time inventory tracking, smart suggestions, and dedicated support for healthcare providers like wellness clinics, med spas, and corporate wellness facilities. Through June 6, 2024, we operated our digital asset mining operations in one hosted facility in Granberry, Texas.

Written from the business description in MedWellAI, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 30 September 2025. Every sentence was checked against that document before publication.

Growth
USD 594,768.00
Revenue, FY2024 · full 14-year series below
Revenue $M Net income $M
FY2024 · Revenue 0.6 · Net income -3.6
2.5M5.0M-10.0M-20.0M20112013201520172019202120232024
Compound annual growth
−55.1%
+5.5%
+8.4%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +5.5% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
−635 cents
lost on every revenue dollar
Operating margin Net margin
FY2024 · Operating -477.6% · Net -635.4%
200%400%600%-1000%-2000%-3000%20112013201520172019202120232024
ROE
FY2022 · ROE -505.0%
100%200%300%-200%-400%20112013201520172019202120232024

Cash & shareholders
returned in FY2024 · dividends + net buybacks
Free cash flow $M
FY2024 · FCF -0.9
-2M-4M20112013201520172019202120232024

Total assetsUSD 805,500.00
EquityUSD -6.6M
CashUSD 401,310.00
Current ratio0.14×

Equity funds -822% of total assets.

The 14-year record
14 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 20242023202220212020201920182017201620152014201320122011
Revenue $B0.00.00.00.00.00.00.00.0··0.00.0··
Operating income $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.00.0··
EBITDA $B−0.0−0.0·−0.0−0.0··−0.0······
Income tax $B0.00.00.00.00.00.00.0·······
Net income $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.00.0−0.0−0.0
Free cash flow $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0···0.0··
EPS, diluted $·−2.72−11.98·−0.16−0.02−0.70−0.67··0.000.01·−0.02
Dividend / sh $··············
Payout %··············
ROE %··−505.0−5.8−506.7······344.9··
Shares out B0.010.000.000.000.100.030.030.010.010.030.030.010.010.00

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 59 reconciliationsAUDITED

Reconciled in 14 of 19 fiscal years. 35 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityFinance Services
Listed onOTC market
Incorporated inNevada
Fiscal year endsJune 30
SEC categorysmaller reporting company
Data on record since2011

Share this section

Download image